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1.  INTRODUCTION 
India is predominantly an agricultural country and the pesticides 
are essential for the farmers to ensure a good crop yield.  This explains 
the easy and unrestricted availability of Organophosphorus compounds. 
Unfortunately people commonly use Organophosphorus compounds to 
commit suicide. They are extremely toxic substances with a very high 
mortality and morbidity. WHO estimates that about 3 million people are 
exposed to pesticide poisoning every year and causes about 3,00,000 
deaths per year India has the highest incidence of patients with 
Organophosphorus poisoning in the world 1. Circumstances of 
Organophosphorus poisoning : 
• Intentional     -  85.17 % 
• Accidental     -  4.7 % 
• Occupational  - 5.42 %  
 The case fatality of suicidal poisoning with OPC is 10-20%1. The 
primary reason for this being easy availability of Organophosphorus 
compounds. 
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 Patient’s with Organophosphorus poisoning need specialized care, 
which exerts a large burden on the health care system and the society at 
large. The patients with OPC poisoning are usually physically normal 
otherwise and often they are the sole bread winners of their families. 
Hence any improvement in the treatment modality of OPC poisoning will 
benefit the society at large.  
 Oxidative stress is one of the myriad manifestations of OPC 
poisoning. The immediate and long term consequence of this Oxidative 
stress is still unknown. There is inadequate knowledge about the role of 
ant-oxidant supplements in a patient with OPC poisoning. It is never 
considered in the treatment strategies of patients with OPC poisoning. 
 In this study I propose to measure the Antioxidant levels in patients 
with OPC poisoning and to co-relate it with the clinical condition of the 
patient. 
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2.  AIMS AND OBJECTIVES 
• To classify and stratify the patients with Organophosphorus  
poisoning into different groups  based on the severity of clinical 
features. 
• To determine the Antioxidant levels in patients with OPC   
poisoning and to compare it with antioxidant levels in control 
patients.                
• To analyze the co-relation between the severity of poisoning and         
the levels of   Antioxidants. 
• To analyze the co-relation between the type of OPC consumed and 
the level of of Antioxidants. 
• To analyze the co-relation between Serum cholinesterase level and 
serum Antioxidant levels in a patient with OPC poisoning. 
• To analyze the co-relation between RBC cholinesterase level and 
serum Antioxidant levels in a patient with OPC poisoning. 
• To analyze the implication on the therapeutics based on the 
Antioxidant levels and the markers of Oxidative stress. 
 4
• To analyze the effect of treatment on the Antioxidant levels  in 
patients with OPC poisoning 
• To analyse the co-relation between the Outcome of the patient with 
OPC poisoning and the levels of Antioxidants. 
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3.    REVIEW OF LITERATURE 
3.1 HISTORY 
Human beings have evolved into the most dominant species on this 
planet earth based on one important attribute of human nature – 
Innovation. 
 Human beings right through the course of history have been 
constantly innovating to make the world a more comfortable and safe 
place to live. We have manipulated the nature in such a way that we are 
able to use the natural resources for our benefit and development. As a 
result of this, the population of the world is growing in exponential 
numbers. To feed the billions of hungry mouths we needed to develop 
newer and more efficient ways to grow food crops. This constant and all 
pervasive need to improve our supply of food grains has compelled us to 
develop methods which increase the yield of food grains many fold. 
 Among these developments the development of pestcides is the 
most important. These pesticides are essential to prevent the food crops 
being destroyed by insects, fungi and animals. 2 
 
 6
 Pesticides are not new. Ancient Romans killed insect pests by 
burning sulfur and controlled weeds with salt. In the 1600s, ants were 
controlled with mixtures of honey and arsenic. By the late nineteenth 
century, U.S. farmers were using copper acetoarsenite (Paris green), 
calcium arsenate, nicotine sulfate and sulfur to control insect pests in field 
crops, but results were often unsatisfactory because of the primitive 
chemistry and application methods .3,25, 
 Among all the pesticides which were developed, the 
Oganophosphorus compounds revolutionized the agricultural field and 
paved the way for the Green revolution. 
 Organophosphate (OP) compounds are a diverse group of 
chemicals used in both domestic and industrial settings.  
 Organophosphate compounds were first synthesized in the early 
1800s when Lassaigne reacted alcohol with phosphoric acid. Shortly 
thereafter in 1854, Philip de Clermount described the synthesis of 
tetraethyl pyrophosphate at a meeting of the French Academy of 
Sciences4. 
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Eighty years later, Lange, in Berlin, and, Schrader, a chemist at 
Bayer AG, Germany, investigated the use of organophosphates as 
insecticides. However, the German military prevented the use of 
organophosphates as insecticides and instead developed an arsenal of 
chemical warfare agents (ie, tabun, sarin, soman).5 A fourth agent, VX, 
was synthesized in England a decade later. During World War II, in 1941, 
organophosphates were reintroduced worldwide for pesticide use, as 
originally intended.  
 Massive organophosphate intoxication from suicidal and accidental 
events, such as the Jamaican ginger palsy incident in 1930, led to the 
discovery of the mechanism of action of organophosphates. In 1995, a 
religious sect, Aum Shinrikyo, used sarin to poison people on a Tokyo 
subway. 6       
 Nerve agents have also been used in battle, notably in Iraq in the 
1980s. Additionally, chemical weapons still pose a very real concern in 
this age of terrorist activity. According to WHO stastics Poisoning by 
Pesticides comprise about 30% of all causes of deliberate self harm in 
India1. 
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3.2. CHEMISTRY AND BIOLOGICAL EFFECTS OF 
ORGANOPHOSPHORUS COMPOUNDS 
 Organophosphates (OP) are cholinesterase-inhibiting chemicals 
used predominately as pesticides. They are also used as chemical warfare 
agents (nerve agents). OPs include all insecticides containing 
phosphorous derived from phosphoric acid, and are generally the most 
toxic of all pesticides to vertebrate animals. 
 OPs and carbamates inhibit the function of carboxylic ester 
hydrolases, such as chymotrypsin, acetylcholinesterase (AChE), plasma 
or butyrilcholinesterase (BuChE), plasma and hepatic carboxylesterases 
(aliesterases), paraoxonases (esterases), and other nonspecific esterases 
within the body. 14, 15, 16, 17, 18,The most prominent clinical effects of 
poisoning with OPs result from their inhibition of AChE . 
 Organophosphates can be absorbed cutaneously, ingested, inhaled, 
or injected. Although most patients rapidly become symptomatic, the 
onset and severity of symptoms depend on the specific compound, 
amount, route of exposure, and rate of metabolic degradation. 
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Classification of OPC agents based on leaving group 19 
Group 1: Phosphorylcholines Subsituted  
quartenary N           
Echothiopate 
Group 2: Fluorophosphates                 Fluoride    Dimefox, sarin. 
Group 3: cyanophosphates/ 
Halophosphates                     
CN, SCN, OCN                         Tabun.
Group 4: multiple 
constituents           
“R group” 
Dimethoxy                      Chlorothion, 
Methylparathion 
Dichlorvos, Fenthion  
Temephos, Malathion  
 
Diethoxy Chlorfenvinphos, 
Ethion, Phorate, 
TEPP, diazinon, 
Parathion, 
Coumaphos  
 
Dialkoxy Isopropyl paraxoan 
 
Diamino Schradan 
 
Chlorinated/ subs 
dialkoxy 
Haloxan 
 
Trithioalkyl  Merphos 
 
Triphenyl TOCP 
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General structure of OPC compounds 19 
 
 
Fig : 1 
3.3. PATHOPHYSIOLOGY OF OPC POISONING  
 The primary mechanism of action of organophosphate pesticides is 
inhibition of carboxyl ester hydrolases, particularly acetylcholinesterase 
(AChE). AChE is an enzyme that degrades the neurotransmitter 
acetylcholine (ACh) into choline and acetic acid. ACh is found in the 
central and peripheral nervous system, neuromuscular junctions, and red 
blood cells (RBCs).  
 Organophosphates inactivate AChE by phosphorylating the serine 
hydroxyl group located at the active site of AChE. The phosphorylation 
occurs by loss of an organophosphate leaving group and establishment of 
a covalent bond with AChE. 6 
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 Once AChE has been inactivated, ACh accumulates throughout the 
nervous system, resulting in overstimulation of muscarinic and nicotinic 
receptors. Clinical effects are manifested via activation of the autonomic 
and central nervous systems and at nicotinic receptors on skeletal muscle. 
Once an organophosphate binds to AChE, the enzyme can undergo 1 of 
the following 3 processes:  
• Endogenous hydrolysis of the phosphorylated enzyme by esterases 
or paraoxonases  
• Reactivation by a strong nucleophile such as pralidoxime  
(2-PAM) 6 
• Complete binding and inactivation (aging)  
 12
 
 
Table 1- Clinical manifestations of acute Organophosphate Poisoning 
4, 21-25
 
MUSCARINIC 
 
NICOTINIC NERVOUS SYSTEM 
 
 Diarrhoea 
 Urinary incontinence 
 Miosis 
 Bradycardia 
 Bronchorrhoea 
 Bronchoconstriction 
 Salivation 
 Lacrimation 
 Emesis 
 Hypotension 
 Cardiac arrhythmias  
 Fasciculations 
 Tremors 
 Muscle 
weakness with 
respiratory 
failure 
 Hypertension 
 Tachycardia 
 Sweating 
 Mydriasis 
 
 
 Altered sensorium. 
 Seizures. 
 Tremors 
 Type 1 paralysis 
(Acute cholinergic 
crisis) 
 Type 2 paralysis 
(Intermediary 
syndrome) 
 Type 3 paralysis 
(Delayed OPC induced 
neuropathy) 
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Table 2- Peradeniya organophosphate poisoning score 
Parameter            score 
 Miosis 
 Pupils > 2mm     0 
  Pupils ≤ 2mm     1 
  Pupils pin-point    2 
 Fasciculation 
 None      0 
 Present     1 
 Generalized/ continuous & cyanosis  2 
 Respiration 
 ≤ 20/ min                        0 
 > 20/ min     1 
 > 20/ min & cyanosis.    2 
 
 Heart rate 
 
 > 60 /min     0 
 41-60 /min     1 
 ≤40 /min     2 
 
 Level of consciousness 
 
Conscious / alert     0 
Impaired, responds to verbal commands  1 
No response to verbal commands   2 
Convulsions      +1 
_____________________________________________________________________ 
 
Total score ( Max score – 11) 
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3.4  OXIDATIVE STRESS AND ANTIOXIDANTS 
FREE RADICALS  
 It is ironic that oxygen, an element indispensable for life, under 
certain situations has deleterious effects on the human body. Most of the 
potentially harmful effects of oxygen are due to the formation and 
activation of a number of chemical compounds, known as reactive 
oxygen species, which have a high tendency to donate oxygen to other 
substances.7,8,9  
 Many such reactive species are free radicals, i.e. molecules with 
one or more unpaired electrons and therefore unstable and highly 
reactive. Free radicals have various chemical structures, such as hydroxyl, 
superoxide, nitric oxide and lipid peroxyl radicals.    
 Seeking stability, radicals attack nearby molecules to obtain 
another electron and this damage the structure and function of the 
molecule.  
 If free radicals are not inactivated, their chemical reactivity can 
damage all cellular macromolecules, including proteins, carbohydrates, 
lipids and nucleic acids Free radicals have the ability to change the 
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structure of DNA and serve as a precursor of cancer by inducing 
genotoxicity.  
 Free radicals and other reactive oxygen species are derived either 
from normal essential metabolism in the human body or from external 
sources, such as exposure to rays, ozone, cigarette smoking, certain 
drugs, pesticides, air pollutants and industrial chemicals. 
 Free radical formation occurs continuously in cells as a 
consequence of both enzymatic and non-enzymatic reactions. 
 The balance between the production of free radicals and 
antioxidant defenses in the body has important health implications: if 
there are too many free radicals or too few antioxidants for protection, a 
condition of oxidative stress develops, which may cause chronic and 
permanent damage. 
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ANTIOXIDANTS 
 The human body has several mechanisms to counteract the damage 
caused by free radicals. The basic and the most prominent defense 
mechanism of the human body is antioxidant agents. The term 
antioxidant has been defined as any substance that delays or inhibits 
oxidative damage to a target molecule. These molecules are stable 
enough to neutralize free radicals by donating electrons. Today many 
compounds have been found to have antioxidant activity, but in the 
human body they can be categorized in two main systems. The main 
system of defense against damage from free radicals is the enzymatic 
system that opposes oxidation. 27-32 
 The body maintains pools of the antioxidant vitamins, such as 
vitamin E, vitamin C, and beta-carotene, the vitamin A precursor. This 
first defense system tries to handle all free radicals, but if the oxidative 
stress is far greater than the capacity of the system, the second line of 
defense (vitamins) may come into play. Vitamins scavenge and quench 
free radicals, but are oxidized and inactivated in the process. Each of 
these antioxidant nutrients has specific activities, and they often work 
synergistically to enhance the overall antioxidant capacity of the body27. 
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3.5  PESTICIDES AND OXIDATIVE STRESS 
 The widespread use of Organophosphorus compound pesticides in 
public health and agricultural programs has caused severe environmental 
pollution and health hazards, including cases of severe acute and chronic 
human poisoning . The introduction of new, more toxic and rapidly 
disseminating Organophosphorus compound pesticides into the 
environment has necessitated accurate identification of their potential 
hazards to human health. 
 These toxic chemicals have become an integral part of the 
ecosystem, although many of them are extremely toxic to mammals and 
other non-target creatures. However, the implications of pesticide 
residues for human health have yet to be comprehensively documented.27  
 Free radicals play an important role in the toxicity of 
Organophosphorus compound pesticides and environmental chemicals , 
they  may induce oxidative stress, leading to generation of free radicals 
and alteration in antioxidants, oxygen free radicals, the scavenging 
enzyme system, and lipid peroxidation. 
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 Several studies have demonstrated oxidative stress induced by OPs 
in rats and humans. It is reported that OPIs, besides their inhibitory effect 
on AChE, also induce changes characteristic of oxidative stress.  
 Superoxide dismutase (SOD), whose substrate is a free radical 
(superoxide anion; O2•-) catalyzes dismutation reaction resulting in the 
generation of hydrogen peroxide (H2O2). This H2O2 is decomposed to 
water and molecular oxygen by the action of catalase. When the free 
radical production overwhelms the endogenous antioxidant levels, they 
cause considerable cell damage/death. 
 All the major biomolecules like lipids, proteins, and nucleic acids 
may be attacked by free radicals, but lipids are probably the most 
susceptible.The oxidative destruction of lipids (lipid peroxidation) is a 
destructive, self-perpetuating chain reaction, releasing malonyl 
dialdehyde (MDA) as the end product. M. Dandapani et al 20  have 
proposed oxidative stress as a causative factor in the pathogenesis of 
Intermediary syndrome. Vidyasagar J et al27 proposed the role of 
oxidative stress in their study of patients with OPC poisoning. 
 Pena-Llopis, Samuel   had proposed that Antioxidants can be used 
as safe adjuntive treatment in patients with Organophosphorus Poisoning 
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in the article ‘Antioxidants as Potentially Safe Antidotes for 
Organophosphorus Poisoning.’ 26 
 In view of the possible oxidative stress involved in OPC Poisoning, 
the levels of SOD, MDA, Total  Antioxidants, RBC cholinesterase, 
Serum Pseudocholinesterase levels were determined as an index of 
antioxidant status and oxidative stress. 
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4.  MATERIALS AND METHOD 
SETTING 
 The study was conducted at the Poison Control, Training and 
Research Centre of Madras Medical College and Government General 
Hospital, Chennai. 
DESIGN OF STUDY: Descriptive. 
PERIOD OF STUDY: Jan 2008 to June 2008. 
ETHICAL CLEARENCE: Obtained. 
INFORMED CONSENT 
 Informed consent from all the patients /    attendants was obtained. 
MATERIALS  
 All patients admitted with isolated Organophosphorus Poisoning , 
during the study period were included in the study . 
INCLUSION CRITERIA  
 All patients with OPC poisoning admitted during the study period. 
The poisoning with OPC compounds was confirmed by detailed history, 
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physical examination, circumstantial evidence like container, witness etc . 
The diagnosis was supported by appropriate lab tests like - Gastric 
aspirate analysis for OPC by Thin layer Chromatography. 
EXCLUSION CRITERIA 
a)  Patients with associated poisoning with any other substance 
like Alcohol, Organochlorines, Oduvanthalai, Sedatives, 
Recreational drugs, etc. 
b) Patients/attendants refusing to consent for the study. 
c) Patients with known medical illness such as neuromuscular 
disorders like myasthenia gravis or muscular dystrophy, 
hypokalemic periodic paralysis and conditions known to 
alter biochemical parameters were excluded. 
METHOD  
a) The patients with confirmed & isolated OPC poisoning were 
clinically examined at admission and detailed history was 
taken. 
b) The patient’s Peradeniya Organophosphorus poisoning score 
was calculated at admission on Day 1. 
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c) The patients’ blood (5 ml of serum) was drawn for the 
estimation of Antioxidant levels and for other markers of 
Oxidative stress like Superoxide Dismutase, Catalase, 
Glutathione Reductase, Glutathione transferase on Day 1 
using UV- Spectrophotometer. 
d) Simultaneous blood samples were drawn from age, sex and 
geographically matched healthy volunteers and antioxidant 
levels was estimated in them as control.  
e) The patients’ blood (2ml serum) was drawn on Day 1 to 
estimate the Serum Cholinesterase and RBC Cholinesterase 
levels. 
f) Simultaneous blood samples were drawn from age, sex and 
geographically matched healthy volunteers and Serum 
Cholinesterase and RBC Cholinesterase levels was estimated 
in them as control.  
g) The patient was treated with standard protocol treatment for 
OPC poisoning and supportive treatment like Mechanical 
Ventilation etc was instituted as necessary. 
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h) The Peradeniya Organophosphorus poisoning score of the 
patient was determined on Day 3 and Day 5. 
i) The patients antioxidant levels and Superoxide Dismutase, 
Catalase, Glutathione Reductase, Glutathione transferase 
were repeated on Day 5. 
j) The Serum Cholinesterase and RBC Cholinesterase levels 
were estimated on Day 5. 
k) The results were collated and analysed using standard 
descriptive analysis methods. 
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5.  OBSERVATIONS AND RESULTS 
 Data were analyzed using SPSS 6.0. All continuous variables were 
analyzed using Mann Whitney U test, student-t test, discrete variables 
using Chi-square test (Fisher’s Exact Probability Test). 
Table 3- Type of Poison with outcome Cross-tabulation 
Outcome Type of Poison Improved Death Total 
CHLORPYRIPHOS 3 1 4 
DIMECRON 6 2 8 
DIMETHOATE 2 1 3 
FOLIDOL 12 3 15 
METAPHOS 1 0 1 
MONOCROTOPHOS 8 4 12 
PARATHION 3 1 4 
PHORATE 2 1 3 
TOTAL 37 13 50 
 
 Analysis of the type of OPC compound consumed showed that 
Folidol was the most commonly used compound - 12/50 i.e 24%, 
followed by Monocrotophos - 8/50 i.e 16%. There were 13 deaths out of 
total 50 patients i.e 26%. The maximum deaths were due to 
Monocrotophos - 4/13 i.e 30.2%. 
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Fig : 2 
   
 
 
 
 
 
 
 
 
Fig : 3 
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Table 4 - Quantity of OPC consumed by the patients 
                Outcome N Mean Student independent  
t-test 
Quantity 
(ml) 
Improved 
37 60.65 
t=3.33 P=0.01 
 significant 
  Death 13 179.23  
   
 The patients who survived OPC poisoning had consumed 60.65 ml 
(mean) and the patients who expired had consumed 179.23 ml (mean). 
 The p value was 0.01. The difference in the quantities consumed 
was stastically significant. 
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Table  5 - Duration of Hospital stay 
 The mean duration of hospital stay among the two groups of 
patients is as follows. 
 Outcome N Mean 
Student 
independent t-test 
Hospitalization
(Days) 
Improved 
37 7 
t=1.45 P=0.15 
not significant  
  Death 13 9  
 
 The mean duration hospital stay among the patients who improved 
was 7 days, the duration was 9 days in patients who expired. The 
difference in the duration of hospital stay was not stastically significant. 
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Table 6 - Peradeniya Organophosphorus Poisoning (POP)scale : 
Comparision between scores on Day 1 and Day 5 
 Outcome n Mean 
POP Day 1 Improved 37 5 
  Death 13 9 
POP Day 5 Improved 37 4 
  Death 13 7 
 
 The Peradeniya Organophosphorus poisoning scale was calculated 
in all patients. The mean POP score on Day 1 in patients with poisoning 
who survived was 5/11 and 4/11 on Day 5. The mean POP score on Day 
1 in patients with poisoning who expired was 9/11 and 7/11 on Day 5. 
 The POP score was significantly higher in patients who succumbed 
to OPC poisoning. 
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Fig: 5 
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Table – 7 Comparision between Antioxidant levels in patients with 
OPC poisoning and Normal controls 
GROUP Student 
independent  
t-test 
 
Parameter studied 
Study 
Group 
N = 50 
Control  Group 
N = 30 T p - value 
TotTotal  Antioxidants  
(m.mol/L) 
1.66 +/- 0.14 0.94 +/- 0.10 25.64 0.001 
SOD  
(mic.mol/Hb gm%) 
7.47 +/- 1.06 4.53 +/- 0.70  
13.64 0.001 
CATALASE  
(mic.mol/Hb gm%) 
5.54 +/- 0.81 2.92 +/-0.56 
15.49 0.001 
Glutathione Reductase  
(mic.mol/Hb gm%) 
11.00 +/- 
1.32 
9.58 +/-0.56 
5.52          0.001 
Glutathione 
Transferase  
(mic.mol/Hb gm%) 
6.02 +/- 0.66 5.02 +/- 0.87 
5.78 0.001 
       
 The antioxidant levels were compared between Healthy controls 
and the Patients. As evident from the table above all the antioxidants 
were increased in the patients with OPC poisoning . The Total 
Antioxidants in control was 0.94 +/- 0.10 SD. This was significantly 
higher in patients with OPC poisoning 1.66 +/-0.14. Similarly all the 
Antioxidant levels measured were increased in patients with OPC 
poisoning. p – value was less than 0.001 in all the measured parameters. 
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Fig : 6 
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Table – 8 Comparision between MDA levels in patients with OPC 
poisoning and Normal controls 
GROUP Student 
independent t-test 
Parameter 
studied 
 
 
Study Group 
n= 50 
Control  
Group 
N = 30 
t-value p - value 
 
MDA 
(n.mol/ml) 
2.10 +/- 0.65 
 
1.25 +/- 
0.08 
 
 
 
7.09 0.001 
 
 
 
 The MDA levels were 2.10 +/- 0.65 in the patients with OPC 
poisoning and 1.25 +/- 0.08 in normal controls. The levels were 
significantly elevated in patients with OPC poisoning. 
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Table 9 - Comparision between Antioxidant levels in patients with 
OPC poisoning on Day 1 and Day 5 
  Outcome N Mean Std 
Deviation 
Student 
independent 
t-test 
Total Antioxidants 
D 1 
Improved 37 0.95 0.10 0.01 
  Death 13 0.92 0.08 0.02 
Total Antioxidants 
D 5 
Improved 37 1.81 0.37 0.06 
  Death 13 1.17 0.27 0.07 
SOD D 1 Improved 37 7.58 1.13 0.18 
  Death 13 7.17 0.78 0.21 
SOD D 5 Improved 37 6.63 0.58 0.09 
  Death 13 6.51 0.47 0.13 
CATALASE D 1 Improved 37 5.57 0.77 0.21 
  Death 13 5.53 0.84 0.13 
CATALASE D 5 Improved 37 4.28 0.59 0.09 
  Death 13 4.23 0.60 0.16 
Glutathione 
Reductase D 1 
Improved 37 10.73 1.21 0.33 
  Death 13 11.09 1.36 0.22 
Glutathione 
Reductase D 5 
Improved 37 9.13 0.54 0.09 
  Death 13 8.99 0.72 0.20 
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  Outcome N Mean Std 
Deviation 
Student 
independent 
t-test 
Glutathione 
Transferase D 1 
Improved 37 6.08 0.66 0.10 
  Death 13 5.84 0.66 0.18 
Glutathione 
Transferase D 5 
Improved 37 5.24 0.29 0.05 
  Death 13 5.03 0.53 0.14 
 
 The Antioxidant levels were increased in all the patients with OPC 
poisoning. The Antioxidant levels were higher on Day 1 than Day 5. the 
difference between the levels of Antioxidants on Day 1 and Day 5 was 
not significant. The difference in the increased Antioxidant levels 
between patients who improved and the patients who died was also not 
significant. 
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Table 10 - Comparison of RBC Cholinesterase levels on Day 1 and 
Day 5 between patients who improved and those who expired 
 Outcome 
N Mean Std. Deviation 
Student 
indepen
dent t-
test 
RBC Cholinesterase 
(mcg/ml) D 1 
Improved 37 145.68 10.79 1.77 
  Death 13 145.92 9.14 2.53 
RBC Cholinesterase 
(mcg/ml) D 5 
Improved 37 216.54 46.27 7.60 
  Death 13 229.62 44.93 12.46 
 
 The RBC Cholinesterase levels were reduced on Day 1 in both 
group of patients and they had increased on day 5 in both group of 
patients. The difference in the RBC Cholinesterase levels between the 
patients who improved and the patients who expired was not significant. 
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Table 11 - Comparison of Plasma Cholinesterase levels on Day 1 and 
Day 5 between patients who improved and those who expired 
Parameter Outcome 
N Mean Std. Deviation 
Student 
independent 
t-test 
Pl. Cholinesterase 
D1 (mcg/ml.) 
Improved 37 65.43 11.13 1.83 
  Death 13 59.31 7.46 2.07 
Pl Cholinesterase  
D 5 (mcg/ml.) 
Improved 37 125.92 18.13 2.98 
  Death 13 134.62 21.04 5.83 
 
 The Plasma Cholinesterase levels were reduced on Day 1 in both 
group of patients and they had increased on day 5 in both group of 
patients. The difference in the Plasma Cholinesterase levels between the 
patients who improved and the patients who expired was not significant. 
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6.  DISCUSSION 
 The Organophosphorus compounds are one of the commonly used 
methods to commit suicide in India. Extensive work has been done 
Worldwide on the various aspects of the Organophosphorus compound 
poisoning, including the socio-demographic, clinico-pharmacological 
profile, treatment and outcome modalities. Since OPC poisoning is one of 
the predominant causes of suicides in India and other developing 
countries, any improvement in our knowledge about the management of 
OPC poisoned patient will go a long way in reducing the high mortality 
and morbidity associated with OPC poisoning.  
 In this study conducted at the Poison Control Treatment and 
Research center of Govt General Hospital, Chennai, apart from the 
routine socio-demographic and clinical profile of the OPC poisoned 
patients, the Anti-oxidants levels of the patient and the RBC 
cholinesterase and Plasma cholinesterase levels of the patients were 
estimated using UV-spectrophotometry and their levels were compared 
with that of normal healthy controls. The Anti-oxidants levels of the 
patient and the RBC cholinesterase and Plasma cholinesterase levels were 
estimated on Day 1(at the time of admission) and on Day 5.  
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 In this study the clinical profile of the OPC patients were classified 
using the Peradeniya Organophosthorus-Poisoning(POP scale). This scale 
was developed in the University of Peradeniya, Srilanka. The advantage 
of this scale over other scales like Modified Drieshbach’s Criteria etc, is 
that this score is more accurate and even minor changes in the clinical 
condition of the patient with OPC poisoning can be detected and recorded 
for comparison. With the help of this scoring, the prognosis and the 
course of the patient can be accurately monitored.   
 In this study I have attempted to correlate the Peradeniya 
Organophosthorus-Poisoning(POP scale) score of the patients with the 
Serum anti-oxidants levels and the RBC, Plasma Cholinesterase levels. 
 In this study the confounding factor in the estimation of serum anti-
oxidant levels could be the patients underlying general health condition. 
Many diseases like Diabetes Mellitus, Hypertension, Metabolic 
syndrome, Neuro-degenerative disorders like Alzheimer’s disease can 
have alteration in the antioxdants levels 23. Other factors like smoking, 
alcoholism, drug abuse, exposure to environmental pollutants can also 
increase the oxidative stress in the human body 21,22,24.  
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 In the study conducted 50 patients with confirmed and isolated 
OPC poisoning were included. Patients with multiple, mixed poisonings 
were excluded. The patients on admission received the routine treatment 
protocol for OPC poisoning. They received Inj. Atropine, Inj. P2AM, 
supportive measures like body wash, Bowel decontamination, 
Mechanical ventilation etc.  
6.1 Peradeniya Organophosphorus poisoning (POP) score 
 The Peradeniya Organophosphorus poisoning score (POP) was 
calculated in all the patients at admission, day 5 and in between. Out of 
the 50 patients studied 37 survived and 13 succumbed. The mean POP 
score among survivors was 5/11 on day 1 and 4/11 on day 5. The mean 
POP score in the patients who died was 9/11 on day 1 and 7/11 on day 5. 
The difference in the POP score between the survivors and the patients 
who died was significant. A higher score was indicative of increased 
mortality, morbidity and the need for mechanical ventilation. Hence, POP 
score can be used in all patients with OPC poisoning to predict the 
outcome and course of hospital stay. It is better than modified 
Drieshbach’s criteria, Namba-scoring in predicting the outcome and 
course of hospital stay14.  
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6.2  Total Anti-oxidant levels 
 The mean total Anti oxidants levels among the patients with OPC 
poisoning was 1.66 m.mol/L and in normal controls was 0.94 m.mol/L. 
The anti-oxidants levels in the patients with OPC poisoning was 
significantly elevated when compared to normal controls. The total anti-
oxidant levels of patients on day 1 and day 5 was measured. The mean 
total anti oxidant levels in the patients who improved was 0.95 m.mol/L 
+/- 0.10 SD on day 1 and 1.81 m.mol/L +/-0.37 SD on day 5. The mean 
total anti oxidant levels in the patients who expired was 0.92 m.mol/L +/- 
0.08 SD on day 1 and 1.17 m.mol/L +/- 0.27 SD on day 5.  
 The anti-oxidants levels were elevated significantly due to the 
oxidative stress produced by the OPC compounds. In condition of acute 
oxidative stress, this is a defense mechanism of the body.  
 However, the severe oxidative stress due to OPC compounds 
overwhelms the anti-oxidants capacity of the body and eventually there is 
a decline in the anti-oxidant levels. Hence, in contrast to acute OPC 
poisoning the anti-oxidant levels in chronic OPC poisoning is reduced. 
 In a study by  Surapaneni et al 37,38 It was observed that there was 
a significant increase in erythrocyte MDA levels; SOD, GPX and plasma 
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GST activities; and a significant decrease in erythrocyte GSH, ascorbic 
acid, plasma vitamin E levels and catalase activity in patients with 
Chronic diseases like Diabetes Mellitus, Osteoarthritis etc when 
compared to controls. They concluded that the increased activities of 
antioxidant enzymes may be a compensatory regulation in response to 
increased oxidative stress. 
 There was no significant difference in the anti-oxidants levels 
between OPC survivors and expired patients. This could be due to the 
fact that even non-fatal quantities of OPC compounds can cause 
significant oxidative stress. This finding reinforces the importance of 
oxidative stress in OPC poisoning. 
6.3  Individual Anti-oxidant levels ; (SOD, Catalase, GSH, GR) 
 Super oxide dismutase levels (SOD), catalase, Glutathione 
Reductase, Glutathione Transferase levels were measured ,the levels of 
these anti-oxidants were significantly elevated in patients with OPC 
poisoning when compared with normal healthy controls. The patients 
super oxide dismutase levels (SOD), catalase, Glutathione Reductase, 
Glutathione Transferase levels were measured on day 1 and day 5. They 
were significantly elevated, however the difference between day 1 and 
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day 5 levels was statistically insignificant. This is probably due to the 
long duration of oxidative stress produced by the OPC poisons.  
 In a study Changes in antioxidant enzymes in humans with long-
term exposure to pesticides by Olga López et al 39, a cohort of 81 
intensive agriculture workers (pesticide sprayers) was assessed twice 
during the course of a spraying season for changes in erythrocyte 
antioxidant enzymes. Acetylcholinesterase (AChE) was used as a 
reference biomarker. Sprayers presented lower levels of superoxide 
dismutase (SOD) and glutathione reductase (GR) as compared to controls 
independently of age, BMI, smoking habit or alcohol consumption. In 
their study they found that  Paraoxonase (PON1) polymorphism 
influenced erythrocyte Catalase and Glutathione Reductase, as subjects 
with the R allele presented lower Catalase and higher Glutathione 
Reductase levels. Similar studies have been  were reported by workers 
from India also, a study by A. Prakasam et al,Plasma and RBCs 
antioxidant status in occupational male pesticide sprayers 34, done in  
Annamalai,Tamil Nadu, had different conclusions. The concentration of 
antioxidants such as glutathione (GSH), α-tocopherol, ascorbic acid and 
ceruloplasmin were significantly altered when compared to controls, and 
the activities of antioxidant enzymes were remarkably elevated (P<0.001) 
in sprayer populations, when compared to controls. The important 
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difference between my study  and that of Olga Lopez et al is that the 
Antioxidant levels were elevated. Similar findings are also report by other 
workers from India. 
 The genetic variation in the Paraoxonase (PON1) polymorphism 
may explain these differences.35,36,37 This may explain the varying levels 
of various Antioxidant levels in the OPC poisoned patients. In this study 
the Antioxidant levels were measured in people with long term exposure 
to OPC compounds , hence the levels of superoxide dismutase (SOD) and 
Glutathione reductase (GR) were reduced as compared to my study where 
they were elevated.  
6.4  Malonyl Dialdehyde (MDA) Levels 
 Malonyl aldehyde(MDA) levels were also measured. MDA levels 
are indicative of lipid peroxidation. The levels of MDA was 2.10 
n.mol/ml +/- 0.65 SD in the OPC patients and 1.25 n.mol/ml +/- 0.08 SD 
in normal controls. 
 The levels were significantly elevated in the OPC patients. There 
was no statistically significant difference in the MDA values between the 
survivors and the patients who expired. There was no statistically 
significant difference in the MDA values from day 1 to day 5. This could 
 47
be probably due to the severe and prolonged oxidative stress due to OPC 
poisoning. 
 In a study Biomonitoring of organochlorines, glutathione, lipid 
peroxidation and cholinesterase activity among pesticide sprayers in 
mango orchards by Vipul K. Singh et al 41, assay of acetyl and 
butyrylcholinesterases (AChE, BChE respectively) was done as an 
indirect measurement of OP exposure and levels of Malonyl dealdehyde 
(MDA) and Glutathione (GSH) were estimated in blood samples to 
determine their impact on redox potential in 31 sprayers and compared 
with 18 controls. Significantly inhibited AChE, BChE activities and 
higher MDA level were found among sprayers compared to controls. 
 In this study MDA levels were found to be elevated, which is in 
concurrence with findings of my study, however the GSH levels were 
found to be low in this study in contrast to the findings of my study. This 
could be explained by the difference in the nature of poisoning. In my 
study, all the patients had acute poisoning in contrast to the chronic 
nature in the above study. The small sample of the study may also be 
contributory to the differences in the findings.  
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6.5  Plasma  and RBC Cholinesterase levels 
 The Plasma Cholinesterase level was measured in the 50 OPC 
patients and 30 normal controls. The mean Pl. Ch. levels in the normal 
control was 175.40 microns/ml +/- 8.92 SD and it was 83.84 microns/ml 
+/- 10.58 SD in OPC poisoning patients. The Pl. Ch. levels was 
significantly reduced in OPC poisoned patients. There was however no 
statistically significant difference in the Pl.Ch.levels between the 
survivors and the patients who expired. The Plasma cholinesterases  
levels were reduced in my study as universally seen in all patients. The 
RBC Cholinesterase levels were reduced on Day 1 in both group of 
patients and they had increased on day 5 in both group of patients. The 
difference in the RBC Cholinesterase levels between the patients who 
improved and the patients who expired was not significant. 
6.5.  Co-relation analysis between POP score of the patient and the 
Anti-oxidant levels  
 There was co-relation between the POP score and the serum Anti-
oxidant, MDA levels. The Antioxidant levels were elevated in all cases of 
OPC poisoning irrespective of the POP score. However the POP score 
was not predictive of the increase in the Antioxidant levels. This is due to 
the severe and prolonged oxidative stress produced by the OPC 
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compounds. Even small quantities of OPC compounds were capable of 
producing oxidative stress, however they may not produce markedly 
deranged clinical parameters. The POP score is a clinical score hence it 
has its own limitations in detecting biochemical derangements. 
 There was no variation in the POP score due to age, sex 
diffrerences among the victims. Similarly there was no difference in the 
Antioxidant levels in the patients which could be attributed to the sex of 
the patient, quantity of the OPC consumed. The treatment given did not 
influence the Antioxidant levels. 
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Pathophysiology of Oxidatve stress in patients with OPC poisoning 
 Free radicals are atoms or molecules containing one or more 
unpaired electrons: they are unstable and strive to restore parity. The 
oxygen—centered radicals which are produced under normal aerobic 
metabolism are also called reactive oxygen species (ROS); they are 
mainly produced by leukocytes and by the respiratory mitochondrial 
chain; they are essential for cell signaling, and for defense against 
infections. Another category of free radicals are derived from nitric oxide 
metabolism (NOS) and is the normal byproduct of endothelial 
metabolism. 
  Induction of reactive oxygen species by Organophosphorus 
Compounds and subsequent depletion of antioxidant cell defenses can 
result in disruption of the pro-oxidant / antioxidant balance in human 
tissues. The events following acute OPC provide a conducive setting for 
free radical generation 37-39,43,44,45. 
 The main cause of morbidity due to organophosphate poisoning is 
intermediate syndrome (Type II paralysis) that can occur 48-72 h after 
poisoning. In acute organophosphate poisoning, severe and prolonged 
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acetylcholinesterase inhibition is associated with oxidative stress, 
detected in erythrocyte membranes, that occurs early in the course of 
poisoning and may contribute to the development and severity of 
Intermediate syndrome. It may also be responsible for delayed 
Polyneuropathy. Free radicals mediate muscle damage and inflammation 
after strenuous exercise as well as the cellular injury of ischaemia-
reperfusion as proposed by Dandapani et al 31, Lachance PA, Nakat Z, 
Jeong WS 43 . 
 Therefore the extensive muscle fasciculations and overactivity that 
occur in the cholinergic crisis of acute OPP and the paralysis following 
muscle overactivity which simulate ischaemia re-perfusion can both lead 
to free radical production and muscle damage. Studies in rats show that 
organophosphate induced muscle hyperactivity leads to free radical 
production with lipid peroxidation, a contributing factor to 
organophosphate induced cell injury. 
 Similar injury to the muscle may take place in acute OPC and 
contribute to the development of Intermediate syndrome. The source of 
free radicals in acute OPC is probably muscles. Oxidative damage of 
erythrocyte membrane lipid and protein may reflect similar reactions 
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occurring in the myocyte. Free radical damage to myocytes may 
contribute to the muscle weakness in acute OPC.  
 Recent work of Yang et al 39show the inductionof heat shock 
protein 70 (HSP70) in cultured muscle cells exposed to dimethoate. Heat 
shock proteins are known to protect cells from oxidative stress and if 
induced in OPC patients may partly explain the low levels of oxidative 
stress observed in a few patients patients despite their severe poisoning . 
 A study by M. Dandapani, A. Zachariah, Oxidative damage in 
intermediate syndrome of acute organophosphorous poisoning31. 
Showed that Oxidative stress was one of the major cause for the 
development of Intermediary syndrome. 
 Apart from these manifestations of OPC poisoning, according to 
TR Shobha et al 25 transient renal glycosuria has also been observed in 
patients with Organophosphate and Carbamate Poisoning. The proposed 
mechanism of action was probably due to Oxidative stress. 
 The acute and sub acute clinical manifestations of the Oxidative 
stress may be in the form of Respiratory distress, Intermediary syndrome, 
Delayed Polyneuropathy. These may be easily manifest in the POP score 
of the patients. However only a few patients develop these complications. 
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The proposed reasons include polymorphism of the  Paroxanase 1 (PON 
1) gene 39-41. 
 The long-term effects of the severe oxidative stress due to the OPC 
poisoning are yet to be elucidated. A few diseases which are attributed to 
be due to increased oxidative stress are 22,44 : 
1. Accelerated aging 
2. Acute pancreatitis 
3. Allergies 
4. Arthritis and other autoimmune diseases 
5. Asthma 
6. Atherosclerosis 
7. Cancer 
8. Diabetes, diabetic cataract 
9. Drug toxicity 
10. Emphysema 
11. Neuronal stress (related to cognitive function) 
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12. Inflammatory bowel disease 
13. Liver cirrhosis 
14. Macular degeneration of the retina 
15. Micronutrient deficiency 
16. Osteoarthritis 
17. Parkinson's disease and possibly  Alzheimer's disease 
18. Premature retinopathy 
19. Reduced immune system function 
20. Rheumatoid arthritis 
21. Birth defects 
22. Pre – Eclampsia/ Eclampsia 
23. Endothelial dysfunction. 
 Many of the above mentioned diseases have well established 
etiological and genetic basis, however the oxidative stress may accelerate 
and aggravate the primary disease process.  
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 Hence we need to follow up the patients with OPC poisoning for 
any of the above diseases. 
 A therapeutic strategy to increase the antioxidant capacity of cells 
may fortify the long term effective treatment. This may be accomplished 
by either reducing the possibility of toxicants interacting with critical bio-
molecules and inducing oxidative damage, or by bolstering the cells, 
antioxidant defenses through endogenous supplementation of antioxidant 
molecules.  
 Although, many investigators confirmed induction of oxidative 
stress in many instances of diseases or following exposure to toxins, the 
usefulness of antioxidants alone or in conjunction with a drug has not 
been extensively investigated yet 53-54. 
 Antioxidants are substances, which inhibit or delay oxidation of a 
substrate while present in minute amounts. Endogenous antioxidants 
(AOX) defenses are both non—enzymatic (e.g. uric acid, glutathione, 
bilirubin, thiols, albumin, and nutritional factors, including vitamins and 
phenols) and enzymatic (e.g. the Superoxide Dismutases, Glutathione 
peroxidases, and Catalase). In the normal subject, the endogenous 
antioxidant defences balance the production of ROS, but for the average 
1% daily leak, the most important source of Antioxidants is provided by 
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nutrition. These Antioxidants are not adequate to overcome the severe 
Oxidative stress brought by OPC Ingestion 43-48. 
 The patients in my study had received all the standard treatment 
protocols for OPC poisoning like Inj Atropine, Inj P2 AM , Mechanical 
Ventilation, etc. However there was no difference in the Antioxidant 
levels between the patients who received these treatments and those who 
did not. This again re-emphasizes that the Oxidative stress occurs 
irrespective of the type of OPC, Quantity of OPC, Age of the patient, 
treatment received, etc. According to Stohs SJ: The role of free radicals 
in toxicity and disease 44 in considering Antioxidant therapy for patients 
with acute OPC poisoning it may be necessary to use multiple 
Antioxidant combination therapy instead of using a single compound as a 
single compound may cause imbalance in the oxidation-antioxidant cycle. 
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7.  CONCLUSIONS 
 The total Anti-oxidants were significantly elevated in patients with 
OPC Poisoning when compared to normal controls. 
 Individual Anti-oxidants like Super oxide dismutase (SOD), 
Catalase, Malonyl dialdehyde (MDA), Glutathione Reductase, 
Glutathione transferase were significantly elevated in patients with 
OPC Poisonig when compared to normal controls 
 The elevated antioxidant levels could not be attributed to the 
individual type of OPC compound. 
 The elevated antioxidant levels could not be attributed to 
differences in sex, age, geographical location, treatment etc.  
 There was no significant difference in the levels of Total Anti-
oxidants between the patients who survived and the patients who 
died. 
 There was no significant difference in the levels of Individual Anti-
oxidants like Super oxide dismutase (SOD), Catalase, Malonyl 
diadehyde (MDA), Glutathione Reductase, Glutathione transferase 
between the patients who survived and the patients who died. 
 58
 There was no significant difference between the levels of Total 
Anti-oxidants on Day 1 and Day 5 in patients with OPC poisoning  
 There was no significant difference between the levels of 
Individual Anti-oxidants like Super oxide dismutase (SOD), 
Catalase, Malonyl Aldehyde (MDA), Glutathione Reductase, 
Glutathione transferase on Day 1 and Day 5 in patients with OPC 
poisoning  
 There was significant reduction the Plasma Cholinesterase levels of 
patients with OPC Poisoning when compared with normal 
individuals. 
 There was significant reduction the RBC Cholinesterase levels of 
patients with OPC Poisoning when compared with normal 
individuals. 
 There was minimal increase in the levels of Plasma Cholinesterase 
and RBC cholinesterase by Day 5. 
 There was significant co-relation between the Peradeniya   
Organophosphorus Poisoning scale and the outcome, higher score  
indicating poor  prognosis.                                                                                                                                                                                        
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 The increase in the Total Anti-oxidant levels was occurring in all            
patients of OPC poisoning , without any co-relation to the 
Peradeniya Organophosphorus Poisoning scale (POP). 
 The increase in  Super oxide dismutase (SOD), Catalase, Malonyl 
dialdehyde (MDA), Glutathione Reductase, Glutathione transferase 
was occurring in all patients of  OPC poisoning , without any co-
relation to the Peradeniya organophosphorus scale (POP). 
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Limitations of the study 
 In India only one similar study has been done previously by 
Vidyasagar et al 21. the findings of my study are in concurrence with that 
study, however in that study there was no attempt at co-relation between 
the clinical scenario and the anti-oxidant levels. However there were no 
other studies available for comparision from India, hence the results of 
this study need to be validated. 
 In my study the underlying  Anti-oxidant status was not available, 
moreover many conditions like Chronic/occupational exposure to OPC 
compounds, Diabetes Mellitus , Coronary artery disease, Smoking , 
Alcoholism , Normal aging etc can alter the Anti-oxidant status.  
 All these conditions could not ruled out or taken into consideration 
due to lack of adequate history and clinical data, which may cause 
confounding of the data. 
 In my study I could not do a long term follow up on the Clinical 
status and the Anti-oxidant status of the patients as most of the patients 
admitted in our centre are referred from far away peripheral hospitals and 
follow up is difficult due to the distances involved 
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 In my study I did not attempt intervention with Anti-oxidant 
supplements due to non-availability of safe and cheap agents. 
 In this study the controls could not matched accurately with respect 
to the patients as the patients admitted with OPC poisoning are usually 
admitted in an emergency condition with unpredictable and variable 
demographic, clinical and geographic profile. 
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8.  THE ROAD AHEAD... 
 Conventionally the patients with OPC poisoning are treated with 
Inj Atropine, Inj P2 AM , Mechanical Ventilation, etc. The deleterious 
effects of the Oxidative stress in these patients are usually not recognized 
and are ignored. 
 The Oxidative stress produced by the OPC compounds have 
demonstrated by various studies in this regard, however there has been no 
large multi-centric study on the clinical manifestations and implication of 
the OPC induced Oxidative stress. A few studies done in this regard have 
a small size and are not prospective studies. The need of the hour is to 
have large multi-centric long term prospective studies on the role of 
Oxidative stress in OPC poisoned patients.  
 The role of therapeutic intervention in the form of supplemental 
Antioxidants also needs to be explored. Hypothetically the patient may 
benefit from Anti-oxidant supplements along with standard treatment for 
OPC poisoning. Large studies are needed to explore this hypothesis and if 
found true, we may be able to predict and prevent the potentially fatal 
complication of Intermediary syndrome in OPC patients.  
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  This may also be beneficial to people who have occupational 
exposure to OPC compounds like agricultural workers and people living 
in vicinity of agricultural farms . Since they are chronically exposed to 
low dose OPC compounds, they may not have any acute manifestation of 
OPC poisoning, however, they usually have chronic manifestations of 
OPC poisoning. This may be reduced to a certain extent by giving them 
regular Anti-oxidant supplements. 
 Legislative measures to reduce the burden of deaths due to OPC 
poisoning may include banning highly toxic OPC compounds like 
Monocrotophos, Folidol etc. They should be replaced with less toxic 
compounds like Pyrethroids. 
 The role of individual susceptibility to the harmful effects of OPC 
compounds due to genetic variations (PON 1 mutations) should be further 
studied as this may have therapeutic implications in individualizing the 
treatment of patients with either acute OPC poisoning or chronic OPC 
exposure. It may also be used as a tool in pre-employment screening in 
jobs which may involve occupational exposure to OPC compounds like 
agricultural sprayers etc. 
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PROFORMA 
 
Clinical and biochemical profile of patients with OPC poisoning  
 
 
1. Name: 
 
2. Age(yrs): 
 
3. Sex:    M / F 
 
4. Address: 
 
 
5. Occupation: 
 
6. DOA:   __/__/__                 
 
7. Duration of stay in hospital:  
 
8. Outcome:   Improved / Expired  
 
9. OPC consumed: 
 
10. Quantity (ml):  
 
11. Route of exposure: 
 
12. Time since exposure (mins): 
 
13. Suicidal / Accidental / Occupational:  
 
14. Treatment given outside: Yes / No :  
 
 
 
Clinical features 
 
Peradeniya organophosphate poisoning score 
Parameter            score 
 Miosis 
 Pupils > 2mm     0 
  Pupils ≤ 2mm     1 
  Pupils pin-point    2 
 Fasciculation 
 None      0 
 Present     1 
 Generalized/ continuous & cyanosis  2 
 Respiration 
 ≤ 20/ min                        0 
 > 20/ min     1 
 > 20/ min & cyanosis.    2 
 
 Heart rate 
 
 > 60 /min     0 
 41-60 /min     1 
 ≤40 /min     2 
 
 Level of consciousness 
 
Conscious / alert     0 
Impaired, responds to verbal commands  1 
No response to verbal commands   2 
Convulsions      +1 
_____________________________________________________________________ 
 
Total score ( Max score – 11) 
 
 
POP score on         Day 1: _____ 
          Day 3: _____ 
          Day 5: _____  
          Day 7: _____ 
 
Treatment given: 
 
1) Atropine: ___________ 
a) Dose (mg/day): 
 
b) No of days:   
 
 
2) P2AM :___________ 
a) Dose (mg/day): 
 
b) No of days: 
 
3) Others:     
           a) Ventilatory support:    Yes___/No___ 
 
       b) No of days:  
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BIO-CHEMICAL INVESTIGATIONS  
(Antioxidant Levels) 
 
 
Sl 
no 
 
Investigation 
 
D 1 
 
D 5 
 
1) 
 
 
2) 
 
3) 
 
4)  
 
5)  
 
6) 
 
 
7) 
 
8) 
 
9) 
Superoxide dismutase 
(micro.mol/gmHb %) 
 
Catalase (micro mol/ gm Hb%) 
 
Glutathione reductase (mcg/ gm Hb%) 
 
Glutatione peroxidase (mcg/ gm Hb%) 
 
MDA (n.mol/ml) 
 
Glutathione Transferase 
(n.mol/gmHb%) 
 
Total antioxidants (m.mol / L) 
 
RBC Cholinesterase (mcg/ ml) 
 
Plasma Cholinesterase (mcg/ ml) 
  
 
 
 
 
 
 
 
 
 
 
AGE(Yrs) SEX OCC LOCALITY
DUR_HO
S
(Days) Type of Poison
Route of 
Exposure Quantity ml
Time of 
onset 
(Mins)
30 1 1 2 2 FOLIDOL INGESTI 60 45
32 1 1 1 7 CHLORPY INGESTI 50 45
25 1 3 2 7 HINOXAN INHALAT 15 30
23 1 2 1 7 MONOCR TOPICAL 50 45
30 2 1 2 3 PHORATE INGESTI 5 60
55 1 1 1 6 DIMECRO INHALAT 25 120
38 1 1 1 12 DIMECRO INHALAT 265 40
38 1 1 2 15 DIMECRO INGESTI 250 30
23 1 2 1 8 FOLIDOL INGESTI 50 45
20 2 3 2 14 CHLORPY INGESTI 75 40
24 1 2 1 6 TRIPHOS INGESTI 50 30
40 1 2 2 4 FOLIDOL INGESTI 50 30
32 1 3 2 6 EKALUX INGESTI 60 60
35 1 1 1 6 FOLIDOL INGESTI 125 20
45 1 3 1 22 DIMETHOATEINGESTI 220 15
40 1 1 1 6 FOLIDOL INGESTI 440 35
25 1 1 1 5 DIMECRO INGESTI 70 30
42 1 2 2 6 FOLIDOL INGESTI 60 45
21 1 2 2 7 TRIPHOS INGESTI 234 30
54 1 2 1 3 PARATHIOINGESTI 50 30
8 1 2 2 5 DIMECRO INGESTI 200 15
26 1 2 2 6 EKATOX INGESTI 145 60
20 1 2 1 6 FOLIDOL INGESTI 100 20
20 1 1 1 7 DIMECRO INGESTI 100 50
46 1 2 2 5 FOLIDOL INGESTI 65 30
18 1 3 1 9 PARATHIOINGESTI 50 30
25 1 1 2 13 DIMECRO INGESTI 350 20
14 1 2 2 5 CHLORPY INGESTI 40 45
22 1 1 2 5 DIMECRO INGESTI 90 75
50 1 1 2 5 FOLIDOL INHALAT 10 20
23 1 1 2 14 PARATHIOINGESTI 57 60
27 2 1 1 5 FOLIDOL INGESTI 66 45
23 1 2 2 7 DIMECRO INGESTI 25 55
50 1 1 2 5 FOLIDOL INHALAT 5 20
32 1 1 2 3 METAPHOSINGESTI 60 60
28 1 1 1 11 DIMETHOATEINGESTI 30 45
26 1 2 2 6 DIMECRONINGESTI 36 60
18 2 2 1 5 DIMECRO INGESTI 40 20
20 1 1 2 5 TRIPHOS INGESTI 45 90
20 1 2 1 5 EKALUX INGESTI 45 60
17 2 2 2 6 FOLIDOL INGESTI 15 30
23 1 1 2 6 DIMETHOATETOPICAL 100 50
54 1 2 1 3 PARATHIOINGESTI 175 30
32 1 1 1 7 CHLORPY INGESTI 50 45
24 1 2 2 5 HINOXAN INHALAT 10 15
21 1 1 2 6 PHORATE INGESTI 76 120
46 1 2 2 5 FOLIDOL INGESTI 90 30
32 1 3 2 6 FOLIDOL INGESTI 80 60
45 1 3 1 22 BAYTEX INGESTI 145 15
22 1 2 1 5 FOLIDOL INGESTION 70 30
Intention
Time of 
first aid 
(Hrs)
POP Day 
1
POP Day 
3
POP Day 
5
Total 
Antioxidan
ts D 1
Total 
Antioxidan
ts D 5 SOD D 1 SOD D 5 
1 1.50 5 5 2 1.05 1.44 6.63 6.84
1 2.00 5 4 2 0.96 1.91 6.16 6.86
2 6.00 7 5 3 0.96 1.86 7.12 6.16
2 15.00 5 5 3 0.91 2.05 8.05 6.04
1 1.00 6 6 4 0.84 1.99 8.44 5.34
2 1.00 9 9 7 0.91 1.19 8.10 7.12
2 1.00 10 8 7 0.99 0.92 7.92 6.34
1 .50 10 10 6 0.88 0.81 8.10 5.92
1 2.00 6 4 2 0.79 2.21 8.14 6.92
1 1.00 7 7 5 0.84 1.27 6.34 6.16
1 2.00 1 1 5 1.10 1.34 8.54 7.54
1 1.00 6 5 4 0.88 2.28 8.12 6.96
1 2.00 4 3 3 0.82 2.44 9.84 7.54
1 1.00 8 8 5 0.71 1.36 7.12 6.04
1 .50 10 9 6 0.88 0.96 6.92 7.12
1 6.00 10 8 7 0.92 1.05 6.16 6.04
1 2.00 5 6 5 1.03 1.42 6.64 6.73
1 1.00 5 5 4 0.86 2.47 9.82 7.59
1 .75 7 4 5 0.92 1.31 8.06 7.02
1 2.00 6 8 7 1.14 1.26 8.10 6.12
1 3.00 10 9 9 0.99 1.08 7.05 6.34
1 4.00 7 6 3 0.96 1.92 8.02 6.08
1 .50 8 6 7 0.96 1.38 7.12 6.32
1 2.00 5 7 6 0.93 1.89 6.12 6.83
1 1.00 7 4 3 0.92 1.88 7.10 6.22
1 2.00 4 3 3 0.96 2.05 8.12 6.02
1 2.00 10 8 8 0.96 1.10 6.84 7.12
1 2.00 9 9 8 0.84 1.16 8.54 7.12
1 2.00 8 6 5 0.90 1.22 7.18 6.29
2 .75 3 3 3 1.10 1.36 8.56 7.43
1 2.00 5 6 3 0.91 1.90 6.15 6.80
1 1.00 8 6 5 1.26 1.26 8.05 6.12
1 1.00 3 3 3 0.90 1.92 6.11 6.87
2 .75 3 3 2 0.92 1.88 7.10 6.25
1 3.00 6 6 8 0.96 2.05 8.12 6.05
1 8.00 4 6 4 0.91 2.01 8.17 6.10
1 4.00 6 6 3 0.92 2.12 7.22 6.08
1 2.00 5 4 3 0.97 1.92 6.20 6.86
1 2.00 7 7 8 0.90 1.24 7.22 6.28
1 2.00 4 3 2 0.88 2.42 9.88 7.57
1 3.00 4 3 3 1.20 1.48 8.22 7.60
2 20.00 4 7 4 0.82 2.42 9.82 7.54
1 2.00 9 8 8 1.08 1.16 6.16 6.14
1 2.00 4 7 6 0.96 1.90 6.14 6.84
2 6.00 5 7 4 0.92 1.88 7.02 6.18
1 4.00 6 4 4 0.92 1.88 6.22 6.82
1 1.00 8 7 6 0.91 1.20 7.16 6.26
1 2.00 7 6 5 0.96 1.82 7.02 6.18
1 .50 4 7 5 1.08 1.48 6.66 6.80
1 2.00 6 5 5 1.00 1.90 6.19 6.88
 MDA D 1  MDA D 5 
CATALAS
E D 1 
 
CATALAS
E D5
Glutathion
e 
Reductas
e D 1
Glutathion
e 
Reductas
e D 5
Glutathion
e 
Transfera
se D 1
Glutathion
e 
Transfera
se D 5
RBC 
Cholineste
rase D 1
1.84 1.72 5.53 5.16 10.80 9.81 5.83 4.93 161
2.16 2.06 4.06 3.54 13.60 9.20 6.84 5.08 138
1.84 1.82 6.10 3.92 11.40 9.18 5.92 5.59 152
1.38 1.58 6.16 4.16 9.80 9.12 6.84 5.15 132
1.36 1.54 5.54 4.41 11.60 9.54 6.68 5.26 158
2.10 2.16 5.16 4.05 10.20 9.26 6.41 5.19 151
2.31 2.03 5.92 3.84 11.60 9.61 6.91 4.92 141
1.91 1.94 6.62 4.05 10.80 8.86 6.16 5.36 154
2.82 2.71 5.01 4.16 11.20 10.80 4.98 4.91 158
1.28 1.44 4.41 4.48 11.40 10.20 6.32 5.38 39
3.84 3.14 5.15 4.41 10.20 8.96 5.96 5.11 140
1.96 1.94 5.92 5.03 11.70 9.05 5.76 6.02 154
1.64 1.83 6.38 5.02 9.84 8.12 5.43 5.13 152
1.92 1.76 6.34 4.49 12.20 9.60 4.96 4.84 156
1.91 1.84 4.03 3.12 9.80 9.12 5.08 5.01 141
2.83 2.64 5.54 4.16 10.10 9.34 5.62 4.26 146
1.90 1.71 5.55 5.19 10.82 9.87 5.81 4.95 163
1.52 1.82 6.45 5.09 9.89 8.10 5.44 5.17 150
2.61 2.07 5.54 3.39 12.20 9.13 5.81 5.08 148
3.23 3.12 5.90 3.90 10.62 9.22 4.57 6.00 122
2.05 2.03 5.32 4.32 10.80 8.16 6.36 6.02 154
1.40 1.51 6.18 4.17 9.82 9.10 6.86 5.18 140
2.62 2,04 5.84 5.38 10.90 9.96 5.92 4.44 164
2.16 2.06 4.06 3.52 13.53 9.22 6.84 5.02 133
1.81 1.85 6.12 3.95 11.41 9.13 5.88 5.60 150
1.38 1.53 6.12 4.17 9.80 9.11 6.86 5.15 134
3.36 3.12 6.05 4.38 8.89 7.14 5.02 4.92 136
0.98 1.10 5.96 4.48 9.89 9.12 5.84 4.34 138
2.04 1.00 6.11 5.18 9.60 8.60 5.90 5.11 141
3.84 3.20 5.19 4.45 10.20 8.96 5.83 5.09 145
2.10 2.09 4.06 3.50 13.50 9.27 6.88 5.05 131
3.18 3.02 5.86 3.96 10.60 9.24 4.61 6.01 126
2.14 2.04 4.11 3.50 13.56 9.24 6.84 5.00 129
1.92 1.78 6.18 4.02 11.41 9.18 5.90 5.60 154
1.42 1.61 6.21 4.17 9.85 9.32 6.79 5.24 148
1.34 1.53 6.14 4.17 9.72 9.18 6.83 5.20 141
1.48 1.86 6.32 4.23 9.34 9.26 6.66 4.94 156
2.20 2.12 4.02 3.50 13.26 9.26 6.80 5.12 138
2.14 1.15 6.20 5.18 9.64 8.54 5.72 5.12 148
1.61 1.88 6.40 5.08 9.88 8.17 5.47 5.20 162
3.22 3.40 5.22 4.40 10.12 8.40 5.76 5.14 147
1.62 1.88 6.40 5.08 9.81 8.18 5.44 5.13 150
1.66 1.64 5.32 4.12 11.20 8.82 5.08 5.91 138
2.20 1.98 4.16 3.46 13.50 9.28 6.74 5.12 134
1.98 1.84 6.22 4.12 11.44 9.08 5.86 5.48 160
2.22 2.14 4.10 3.52 13.12 9.22 6.82 5.18 140
84.00 1.05 6.16 5.16 9.61 8.61 5.91 5.08 144
1.88 1.86 6.12 3.94 11.40 9.20 5.92 5.62 150
1.88 1.73 5.50 5.20 10.60 9.76 5.72 4.92 160
2.18 2.10 4.10 3.55 13.62 9.22 6.88 5.12 140
RBC 
Cholineste
rase D 5
Pl 
Cholineste
rase D1
Pl 
Cholineste
rase D 5
Ventilator
y support Outcome
310 78 128 1 1
191 51 131 1 1
191 61 121 2 1
172 58 98 1 1
184 44 124 1 1
276 48 137 2 2
272 74 136 2 2
184 66 110 2 2
210 56 196 1 1
217 55 126 2 1
259 71 128 1 1
296 91 150 1 1
282 61 110 1 1
205 54 104 2 2
276 60 141 2 2
191 51 128 2 2
302 78 130 1 1
286 63 115 1 1
183 88 108 1 1
182 80 145 1 1
301 55 131 2 2
179 60 100 1 1
271 54 134 2 2
190 55 133 1 1
193 63 121 1 1
174 57 99 1 1
251 54 192 2 2
196 64 132 2 2
180 68 150 2 1
250 80 130 1 1
200 51 134 1 1
184 78 146 2 1
201 55 133 1 1
190 68 128 1 1
172 60 102 1 1
179 57 106 1 1
184 62 110 1 1
192 58 133 1 1
180 72 140 2 1
282 70 116 1 1
246 82 132 1 1
287 65 114 2 1
192 61 121 2 2
194 62 136 1 2
188 66 120 1 1
198 60 132 1 1
176 68 148 2 2
196 64 122 2 1
312 80 124 1 1
190 55 124 1 1
